Dr. Steven Chinn is a tenured Associated Professor of Otolaryngology - Head and Neck Surgery, Rogel Cancer Center Head and Neck Oncology Program, Director of the Head and Neck Oncology Research Program and Associate Fellowship Program Director for the Head and Neck Surgical Oncology/Microvascular Reconstruction Fellowship at the University of Michigan. He received his medical degree from the Keck School of Medicine at the University of Southern California in 2008, graduating with Honors and was elected to the National Alpha Omega Alpha Honor Medical Society. He then completed his post-graduate surgical training in Otolaryngology-Head and Neck Surgery at the University of Michigan in 2014 during which he completed an 18-month NIH funded research post-doctoral fellowship in the Molecular Genetics and Cellular Biology of Head and Neck Cancer. He then completed a two-year dual fellowship in Head & Neck Surgical Oncology and Microvascular Reconstructive Surgery at the University of Texas MD Anderson Cancer Center. Dr. Chinn also holds a graduate degree (MPH) in Molecular Epidemiology from the University of Michigan School of Public Health.

Dr. Chinn joined the faculty at the University of Michigan in 2016. He is a member of the Head and Neck Oncology Division, an active member of the Head and Neck Oncology Translational Research Program, and a member of the University of Michigan Comprehensive Cancer Center. He is the co-Chair of the head and neck clinical trial committee and an active member of NRG Oncology. His clinical expertise is in the treatment of all types of head and neck cancer, including minimally invasive robotic surgery. He also specializes in complex reconstructive surgery to restore form and function after cancer treatment. He also co-directs the head and neck oncology labs, where his lab focuses on molecular and poly-omics analysis of head and neck cancer, cancer stem cells and cellular plasticity, and integration of digital pathology and machine learning for biomarker development.